Clinical Trial Update: Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 dose-escalation safety study of HPN-100 for urea cycle disorders, completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urea Cycle Disorders

Drugs mentioned

• HPN-100

Snippet

Sponsor: Amgen | Conditions: Urea Cycle Disorders | Phase 2 | Status: COMPLETED | Results posted: 2015-05-12